ARHGEF11 and breast carcinoma: Previous studies show that the expression of the ARHGEF11 isoform containing exon 38 is correlated to the malignant phenotype in breast tumours, which means ARHGEF11 exon 38(+) could be used as a biomarker and target of breast cancer management [88].